Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
26
ASPN Quote, Financials, Valuation and Earnings
Last price:
$2.98
Seasonality move
:
-13.1%
Day range:
$2.92 - $3.00
52-week range:
$2.86 - $14.30
Dividend yield:
0%
P/E ratio:
26.94x
P/S ratio:
0.69x
P/B ratio:
0.80x
Volume:
698.1K
Avg. volume:
2.1M
1-year change:
-75.04%
Market cap:
$245.5M
Revenue:
$452.7M
EPS (TTM):
-$3.72
Analysts' Opinion
-
Consensus RatingAspen Aerogels, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.50, Aspen Aerogels, Inc. has an estimated upside of 130.08% from its current price of $2.97.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $2.97.
Fair Value
-
According to the consensus of 7 analysts, Aspen Aerogels, Inc. has 130.08% upside to fair value with a price target of $6.50 per share.
ASPN vs. S&P 500
-
Over the past 5 trading days, Aspen Aerogels, Inc. has underperformed the S&P 500 by -0.4% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Aspen Aerogels, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aspen Aerogels, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Aspen Aerogels, Inc. reported revenues of $73M.
Earnings Growth
-
Aspen Aerogels, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Aspen Aerogels, Inc. reported earnings per share of -$0.08.
Enterprise value:
243.2M
EV / Invested capital:
0.53x
Price / LTM sales:
0.69x
EV / EBIT:
21.07x
EV / Revenue:
0.69x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
90.57x
Price / Operating cash flow:
91.16x
Enterprise value / EBITDA:
6.66x
Gross Profit (TTM):
$116.1M
Return On Assets:
-46.98%
Net Income Margin (TTM):
-86.52%
Return On Equity:
-74.4%
Return On Invested Capital:
-51.62%
Operating Margin:
-2.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $214.1M | $413.8M | $352.9M | $117.3M | $73M | |
| Gross Profit | $41.7M | $165.4M | $116.1M | $49M | $20.8M | |
| Operating Income | -$60.3M | $43.9M | $11.5M | $17.4M | -$1.8M | |
| EBITDA | -$44.1M | $68.2M | $36.5M | $23.5M | $4.4M | |
| Diluted EPS | -$0.85 | $0.01 | -$3.72 | -$0.17 | -$0.08 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $127.1M | $156.3M | $200.4M | $305.9M | $278.9M | |
| Total Assets | $187.7M | $385.4M | $605.1M | $782.6M | $491.4M | |
| Current Liabilities | $28.3M | $81M | $61.3M | $104.3M | $70.7M | |
| Total Liabilities | $45.2M | $203M | $195.3M | $274.9M | $185.7M | |
| Total Equity | $142.5M | $182.4M | $409.8M | $507.7M | $305.7M | |
| Total Debt | $13.8M | $122.1M | $134.1M | $200.5M | $146.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$63.9M | $7.1M | $52.4M | $20.8M | $15M | |
| Cash From Investing | -$206.3M | -$99.3M | -$49.7M | -$20.8M | -$9.1M | |
| Cash From Financing | $262.8M | $111.1M | $35.9M | $21.7M | -$21.5M | |
| Free Cash Flow | -$270.2M | -$92.2M | $2.7M | -$50K | $5.9M | |
ASPN
Sector
Market Cap
$245.5M
$21.5M
Price % of 52-Week High
20.77%
72.73%
Dividend Yield
0%
0%
Shareholder Yield
-16.55%
-2.68%
1-Year Price Total Return
-75.04%
13.33%
Beta (5-Year)
2.950
0.619
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.01
200-day SMA
Sell
Level
$6.15
Bollinger Bands (100)
Sell
Level
4.02 - 8.04
Chaikin Money Flow
Sell
Level
-86M
20-day SMA
Sell
Level
$3.22
Relative Strength Index (RSI14)
Sell
Level
32.14
ADX Line
Sell
Level
32.76
Williams %R
Buy
Level
-86.0759
50-day SMA
Sell
Level
$4.87
MACD (12, 26)
Sell
Level
-0.43
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Sell
Level
-61.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1991)
Buy
CA Score
(Annual)
Level (0.9958)
Sell
Beneish M-Score
(Annual)
Level (-1.8278)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-3.4789)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aspen Aerogels, Inc. engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. It operates through the Energy Industrial and Thermal Barrier segments. The Energy Industrial segment designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in the energy industrial and sustainable insulation markets. The Thermal Barrier segment is actively developing aerogel products and technologies for the EV market. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee in May 2001 and is headquartered in Northborough, MA.
Stock Forecast FAQ
In the current month, ASPN has received 5 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ASPN average analyst price target in the past 3 months is $6.50.
-
Where Will Aspen Aerogels, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aspen Aerogels, Inc. share price will rise to $6.50 per share over the next 12 months.
-
What Do Analysts Say About Aspen Aerogels, Inc.?
Analysts are divided on their view about Aspen Aerogels, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aspen Aerogels, Inc. is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is Aspen Aerogels, Inc.'s Price Target?
The price target for Aspen Aerogels, Inc. over the next 1-year time period is forecast to be $6.50 according to 7 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ASPN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aspen Aerogels, Inc. is a Buy. 5 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ASPN?
You can purchase shares of Aspen Aerogels, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aspen Aerogels, Inc. shares.
-
What Is The Aspen Aerogels, Inc. Share Price Today?
Aspen Aerogels, Inc. was last trading at $2.98 per share. This represents the most recent stock quote for Aspen Aerogels, Inc.. Yesterday, Aspen Aerogels, Inc. closed at $2.97 per share.
-
How To Buy Aspen Aerogels, Inc. Stock Online?
In order to purchase Aspen Aerogels, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ASPN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ASPN
Sector
P/E ratio
26.94x
19.33x
PEG ratio
0.00x
-0.02x
P/B ratio
0.80x
1.71x
Price / LTM sales
0.69x
1.55x
Growth Metrics
ASPN
Sector
Revenue growth
-37.77%
2.23%
Earnings growth
54.79%
--
Revenue (5-year growth)
26.57%
3.12%
Earnings forecast
-$0.00
$0.02
Profitability
ASPN
Sector
Profitability FY 2024
$187M
--
Return on invested capital
-51.62%
-8.83%
Return on assets
-46.98%
-9.87%
Return on equity
-74.4%
-9.61%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
11
Estimated Next Earnings Date
Feb
5
Balance Sheet
ASPN
Sector
Total cash
$152.4M
$2.6M
Short term investments
--
$229.2K
Total assets
$895.1M
$17M
Long term debt
$146.9M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
